Lysyl tRNA synthetases facilitate amino acylation and play a crucial role in the essential cellular process of translation. They are grouped into two distinct classes (class I and class II). Class I lysyl tRNA synthetase is considered as a drug target for syphilis caused by Treponema pallidum. Comparative genome analysis shows the absence of its sequence homolog in eukaryotes. The structure of class I lysyl tRNA synthetase from Treponema pallidum is unknown and the difficulties in the in vitro culturing of Treponema makes it non-trivial. We used the structural template of class I lysyl tRNA synthetase from the archaea Pyrococcus horikoshii for modeling the Treponema pallidum lysyl tRNA synthetase structure. Thus, we propose the usefulness of the modeled class I lysyl tRNA synthetase for the design of suitable inhibitors towards the treatment of syphilis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1891664PMC
http://dx.doi.org/10.6026/97320630001081DOI Listing

Publication Analysis

Top Keywords

lysyl trna
28
trna synthetase
24
class lysyl
20
treponema pallidum
16
synthetase treponema
8
pallidum lysyl
8
class class
8
class
7
lysyl
7
trna
7

Similar Publications

The average eukaryotic tRNA contains 13 posttranscriptional modifications; however, their functional impact is largely unknown. Our understanding of the complex tRNA aminoacylation machinery in metazoans also remains limited. Herein, using a series of high-resolution cryo-electron microscopy (cryo-EM) structures, we provide the mechanistic basis for recognition and aminoacylation of fully-modified cellular tRNA by human lysyl-tRNA synthetase (h-LysRS).

View Article and Find Full Text PDF

Co-Translational Deposition of N-Acetyl-L-Lysine in Nascent Proteins Contributes to the Acetylome in Mammalian Cells.

Adv Sci (Weinh)

December 2024

Department of Biochemistry and Molecular Biology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China.

Article Synopsis
  • N-acetyl-L-lysine is common in dietary protein, yet its effects on consumers are largely unknown.
  • Research indicates that Lysyl-tRNA synthetase (KARS) integrates this compound into proteins during their synthesis, influencing cellular acetylation levels.
  • This process, called co-translational modification (coTM), allows for the acetylation of proteins in ways that differ from traditional post-translational modifications, potentially expanding our understanding of protein regulation in cells.
View Article and Find Full Text PDF

Ethnopharmacological Relevance: Tinospora sinensis (Lour.) Merr., from the family Menispermaceae, is widely used in Indian folk and Ayurvedic medicine.

View Article and Find Full Text PDF

Assembly of the Human Multi-tRNA Synthetase Complex Through Leucine Zipper Motifs.

J Mol Biol

December 2024

School of Life Science and Biotechnology, KNU Creative BioResearch Group, Kyungpook National University, Daegu 41566, Republic of Korea. Electronic address:

Aminoacyl-tRNA synthetases (ARSs) are responsible for the ligation of amino acids to their cognate tRNAs. In human, nine ARSs form a multi-tRNA synthetase complex (MSC) with three ARS-interacting multifunctional proteins (AIMPs). Among the components of MSC, arginyl-tRNA synthetase 1 (RARS1) and two AIMPs (AIMP1 and AIMP2) have leucine zipper (LZ) motifs, which they utilize for their assembly in an MSC.

View Article and Find Full Text PDF

lysyl-tRNA synthetase inhibitors define the interplay between solubility and permeability required to achieve efficacy.

Sci Transl Med

October 2024

Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK.

Cryptosporidiosis is a diarrheal disease caused by infection with spp. parasites and is a leading cause of death in malnourished children worldwide. The only approved treatment, nitazoxanide, has limited efficacy in this at-risk patient population.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!